403641007: Pseudoscleroderma due to cytotoxic therapy (disorder)

SNOMED CT Concept\Clinical finding (finding)\...

\Skin AND/OR mucosa finding (finding)\Skin or mucosa lesion\Lesion of skin and/or skin-associated mucous membrane\Skin lesion (disorder)\Induration of skin\Sclerosis of the skin\Scleroderma-like secondary cutaneous sclerosis (disorder)\Drug-induced pseudoscleroderma (disorder)\Pseudoscleroderma due to cytotoxic therapy (disorder)
\Skin AND/OR mucosa finding (finding)\Skin finding (finding)\Disorder of skin (disorder)\Drug-induced dermatosis (disorder)\Drug-induced pseudoscleroderma (disorder)\Pseudoscleroderma due to cytotoxic therapy (disorder)
\Skin AND/OR mucosa finding (finding)\Skin finding (finding)\Disorder of skin (disorder)\Drug-induced dermatosis (disorder)\Dermatosis due to cytotoxic therapy (disorder)\Pseudoscleroderma due to cytotoxic therapy (disorder)
\Skin AND/OR mucosa finding (finding)\Skin finding (finding)\Disorder of skin (disorder)\Skin lesion (disorder)\Induration of skin\Sclerosis of the skin\Scleroderma-like secondary cutaneous sclerosis (disorder)\Drug-induced pseudoscleroderma (disorder)\Pseudoscleroderma due to cytotoxic therapy (disorder)

\General finding of soft tissue\Skin finding (finding)\Disorder of skin (disorder)\Drug-induced dermatosis (disorder)\Drug-induced pseudoscleroderma (disorder)\Pseudoscleroderma due to cytotoxic therapy (disorder)
\General finding of soft tissue\Skin finding (finding)\Disorder of skin (disorder)\Drug-induced dermatosis (disorder)\Dermatosis due to cytotoxic therapy (disorder)\Pseudoscleroderma due to cytotoxic therapy (disorder)
\General finding of soft tissue\Skin finding (finding)\Disorder of skin (disorder)\Skin lesion (disorder)\Induration of skin\Sclerosis of the skin\Scleroderma-like secondary cutaneous sclerosis (disorder)\Drug-induced pseudoscleroderma (disorder)\Pseudoscleroderma due to cytotoxic therapy (disorder)
\General finding of soft tissue\Disorder of soft tissue\Lesion of soft tissue (disorder)\Skin lesion (disorder)\Induration of skin\Sclerosis of the skin\Scleroderma-like secondary cutaneous sclerosis (disorder)\Drug-induced pseudoscleroderma (disorder)\Pseudoscleroderma due to cytotoxic therapy (disorder)
\General finding of soft tissue\Disorder of soft tissue\Disorder of skin and/or subcutaneous tissue (disorder)\Disorder of skin (disorder)\Drug-induced dermatosis (disorder)\Drug-induced pseudoscleroderma (disorder)\Pseudoscleroderma due to cytotoxic therapy (disorder)
\General finding of soft tissue\Disorder of soft tissue\Disorder of skin and/or subcutaneous tissue (disorder)\Disorder of skin (disorder)\Drug-induced dermatosis (disorder)\Dermatosis due to cytotoxic therapy (disorder)\Pseudoscleroderma due to cytotoxic therapy (disorder)
\General finding of soft tissue\Disorder of soft tissue\Disorder of skin and/or subcutaneous tissue (disorder)\Disorder of skin (disorder)\Skin lesion (disorder)\Induration of skin\Sclerosis of the skin\Scleroderma-like secondary cutaneous sclerosis (disorder)\Drug-induced pseudoscleroderma (disorder)\Pseudoscleroderma due to cytotoxic therapy (disorder)

\Procedure related finding\Complication of chemotherapy (disorder)\Dermatosis due to cytotoxic therapy (disorder)\Pseudoscleroderma due to cytotoxic therapy (disorder)
\Procedure related finding\Complication of procedure\Complication of introduction procedure\Dermatosis due to cytotoxic therapy (disorder)\Pseudoscleroderma due to cytotoxic therapy (disorder)

\Integumentary system finding\Disorder of integument\Disorder of skin and/or subcutaneous tissue (disorder)\Disorder of skin (disorder)\Drug-induced dermatosis (disorder)\Drug-induced pseudoscleroderma (disorder)\Pseudoscleroderma due to cytotoxic therapy (disorder)
\Integumentary system finding\Disorder of integument\Disorder of skin and/or subcutaneous tissue (disorder)\Disorder of skin (disorder)\Drug-induced dermatosis (disorder)\Dermatosis due to cytotoxic therapy (disorder)\Pseudoscleroderma due to cytotoxic therapy (disorder)
\Integumentary system finding\Disorder of integument\Disorder of skin and/or subcutaneous tissue (disorder)\Disorder of skin (disorder)\Skin lesion (disorder)\Induration of skin\Sclerosis of the skin\Scleroderma-like secondary cutaneous sclerosis (disorder)\Drug-induced pseudoscleroderma (disorder)\Pseudoscleroderma due to cytotoxic therapy (disorder)
\Integumentary system finding\Skin finding (finding)\Disorder of skin (disorder)\Drug-induced dermatosis (disorder)\Drug-induced pseudoscleroderma (disorder)\Pseudoscleroderma due to cytotoxic therapy (disorder)
\Integumentary system finding\Skin finding (finding)\Disorder of skin (disorder)\Drug-induced dermatosis (disorder)\Dermatosis due to cytotoxic therapy (disorder)\Pseudoscleroderma due to cytotoxic therapy (disorder)
\Integumentary system finding\Skin finding (finding)\Disorder of skin (disorder)\Skin lesion (disorder)\Induration of skin\Sclerosis of the skin\Scleroderma-like secondary cutaneous sclerosis (disorder)\Drug-induced pseudoscleroderma (disorder)\Pseudoscleroderma due to cytotoxic therapy (disorder)

\Disease\Complication of chemotherapy (disorder)\Dermatosis due to cytotoxic therapy (disorder)\Pseudoscleroderma due to cytotoxic therapy (disorder)
\Disease\Disorder of body system\Skin or mucosa lesion\Lesion of skin and/or skin-associated mucous membrane\Skin lesion (disorder)\Induration of skin\Sclerosis of the skin\Scleroderma-like secondary cutaneous sclerosis (disorder)\Drug-induced pseudoscleroderma (disorder)\Pseudoscleroderma due to cytotoxic therapy (disorder)
\Disease\Disorder of body system\Disorder of integument\Disorder of skin and/or subcutaneous tissue (disorder)\Disorder of skin (disorder)\Drug-induced dermatosis (disorder)\Drug-induced pseudoscleroderma (disorder)\Pseudoscleroderma due to cytotoxic therapy (disorder)
\Disease\Disorder of body system\Disorder of integument\Disorder of skin and/or subcutaneous tissue (disorder)\Disorder of skin (disorder)\Drug-induced dermatosis (disorder)\Dermatosis due to cytotoxic therapy (disorder)\Pseudoscleroderma due to cytotoxic therapy (disorder)
\Disease\Disorder of body system\Disorder of integument\Disorder of skin and/or subcutaneous tissue (disorder)\Disorder of skin (disorder)\Skin lesion (disorder)\Induration of skin\Sclerosis of the skin\Scleroderma-like secondary cutaneous sclerosis (disorder)\Drug-induced pseudoscleroderma (disorder)\Pseudoscleroderma due to cytotoxic therapy (disorder)
\Disease\Adverse reaction (disorder)\All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting).\Antineoplastic adverse reaction\Dermatosis due to cytotoxic therapy (disorder)\Pseudoscleroderma due to cytotoxic therapy (disorder)
\Disease\Complication of procedure\Complication of introduction procedure\Dermatosis due to cytotoxic therapy (disorder)\Pseudoscleroderma due to cytotoxic therapy (disorder)
\Disease\Drug-induced lesion\Drug-induced pseudoscleroderma (disorder)\Pseudoscleroderma due to cytotoxic therapy (disorder)
\Disease\Disorder of soft tissue\Lesion of soft tissue (disorder)\Skin lesion (disorder)\Induration of skin\Sclerosis of the skin\Scleroderma-like secondary cutaneous sclerosis (disorder)\Drug-induced pseudoscleroderma (disorder)\Pseudoscleroderma due to cytotoxic therapy (disorder)
\Disease\Disorder of soft tissue\Disorder of skin and/or subcutaneous tissue (disorder)\Disorder of skin (disorder)\Drug-induced dermatosis (disorder)\Drug-induced pseudoscleroderma (disorder)\Pseudoscleroderma due to cytotoxic therapy (disorder)
\Disease\Disorder of soft tissue\Disorder of skin and/or subcutaneous tissue (disorder)\Disorder of skin (disorder)\Drug-induced dermatosis (disorder)\Dermatosis due to cytotoxic therapy (disorder)\Pseudoscleroderma due to cytotoxic therapy (disorder)
\Disease\Disorder of soft tissue\Disorder of skin and/or subcutaneous tissue (disorder)\Disorder of skin (disorder)\Skin lesion (disorder)\Induration of skin\Sclerosis of the skin\Scleroderma-like secondary cutaneous sclerosis (disorder)\Drug-induced pseudoscleroderma (disorder)\Pseudoscleroderma due to cytotoxic therapy (disorder)

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 30-Nov 2022. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

1771567012 Pseudoscleroderma due to cytotoxic therapy (disorder) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

1782657019 Pseudoscleroderma due to cytotoxic therapy en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

1787818018 Pseudoscleroderma due to cytotoxic drug en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

1787819014 Scleroderma-like reaction to cytotoxic drug en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

3632651000005110 pseudoskleroderma forårsaget af behandling med cytostatika da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Danish module (core metadata concept)

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Pseudoscleroderma due to cytotoxic therapy (disorder)	Is a	Dermatosis due to cytotoxic therapy (disorder)	true	Inferred relationship	Some
Pseudoscleroderma due to cytotoxic therapy (disorder)	Finding site	Skin structure	true	Inferred relationship	Some	1
Pseudoscleroderma due to cytotoxic therapy (disorder)	Causative agent	Pharmaceutical / biologic product (product)	false	Inferred relationship	Some
Pseudoscleroderma due to cytotoxic therapy (disorder)	Associated morphology	Morphologically abnormal structure	false	Inferred relationship	Some	1
Pseudoscleroderma due to cytotoxic therapy (disorder)	Causative agent	Drug, medicament or biological substance	false	Inferred relationship	Some
Pseudoscleroderma due to cytotoxic therapy (disorder)	Causative agent	A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.	false	Inferred relationship	Some
Pseudoscleroderma due to cytotoxic therapy (disorder)	Causative agent	A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.	false	Inferred relationship	Some
Pseudoscleroderma due to cytotoxic therapy (disorder)	Causative agent	Antineoplastic agent (substance)	false	Inferred relationship	Some
Pseudoscleroderma due to cytotoxic therapy (disorder)	Finding site	Skin structure	false	Inferred relationship	Some	2
Pseudoscleroderma due to cytotoxic therapy (disorder)	Associated morphology	Morphologically abnormal structure	false	Inferred relationship	Some	1
Pseudoscleroderma due to cytotoxic therapy (disorder)	Causative agent	Cytotoxic	true	Inferred relationship	Some	1
Pseudoscleroderma due to cytotoxic therapy (disorder)	Is a	Scleroderma-like secondary cutaneous sclerosis (disorder)	false	Inferred relationship	Some
Pseudoscleroderma due to cytotoxic therapy (disorder)	Due to	The treatment of disease using chemical agents or drugs that are selectively toxic to the causative agent of the disease, such as a virus, bacterium, or other microorganism.	true	Inferred relationship	Some	2
Pseudoscleroderma due to cytotoxic therapy (disorder)	Finding site	Skin structure	false	Inferred relationship	Some	3
Pseudoscleroderma due to cytotoxic therapy (disorder)	Associated morphology	Sclerosis	false	Inferred relationship	Some	3
Pseudoscleroderma due to cytotoxic therapy (disorder)	Is a	Drug-induced pseudoscleroderma (disorder)	true	Inferred relationship	Some
Pseudoscleroderma due to cytotoxic therapy (disorder)	Associated morphology	Sclerosis	true	Inferred relationship	Some	1

Inbound Relationships

Type

Active

Source

Characteristic

Refinability

Group

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
1771567012	Pseudoscleroderma due to cytotoxic therapy (disorder)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
1782657019	Pseudoscleroderma due to cytotoxic therapy	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
1787818018	Pseudoscleroderma due to cytotoxic drug	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
1787819014	Scleroderma-like reaction to cytotoxic drug	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3632651000005110	pseudoskleroderma forårsaget af behandling med cytostatika	da	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	Danish module (core metadata concept)